Based on recent headline ratings, 71% of this readership currently trusts the local media, which has an average score of 92% regionally and is currently trending positivenegative.
Media Trust Score71%

ASLAN Pharmaceuticals Announces First Patient Screened in Study of Eblasakimab in … – BioSpace

SAN MATEO, Calif. and SINGAPORE, Dec. … Eblasakimab is a potential first-in-class monoclonal antibody targeting the IL-13 receptor that has the …

  • You already voted!
  • Read More